Market evolution: Medicated dressings (CN 300590) — 2015–2025
Introduction
This report examines the evolution of EU extra-EU trade in CN 300590 — a residual heading covering wadding, gauze, bandages and similar medicated articles excluding adhesive dressings — over the period 2015–2025. The data reveals a striking structural transformation: the EU shifted from a modest net-importing position in 2015 to a clear net-exporting one by 2025, with the trade balance swinging from −€130 million to +€105 million. This transformation was driven not by volume growth but almost entirely by a sharp increase in export unit values, while import volumes continued to grow at stable prices. The report dissects this price-driven upgrading, the evolving geography of trade partners, and the divergent trajectories of the product's four sub-categories.
Product overview on Trade Dashboard
1. A Price-Driven Reversal of the EU's Trade Balance
The EU transitioned from net importer to net exporter in value terms
In 2015, the EU recorded a trade deficit of €130 million with non-EU countries on CN 300590, importing €640 million while exporting €509 million. By 2025, this position had entirely reversed: imports stood at €712 million against exports of €817 million, yielding a surplus of €105 million. The net import reliance indicator swung from +10.4% to −12.9%, confirming that the EU moved from mild import dependence to a structurally export-oriented position. This shift was gradual through 2019, accelerated during the pandemic years, and consolidated after 2022.
Export value growth was almost entirely driven by rising unit prices
The headline 60.4% increase in EU export value (from €509 million to €817 million) masks a critical compositional fact: export volumes actually declined by 3.6%, from 24,530 tonnes in 2015 to 23,640 tonnes in 2025. The entire value increase was therefore driven by a 66.5% surge in the average export unit price, which rose from €20,751/tonne to €34,540/tonne — the highest level in the entire series. This pattern points to a significant value-upgrading dynamic: EU exporters appear to have shifted their product mix toward higher-value-added medicated articles rather than competing on volume.
| Indicator | 2015 | 2025 | Change |
|---|---|---|---|
| Export value (€ million) | 509 | 817 | +60.4% |
| Export volume (tonnes) | 24,530 | 23,640 | −3.6% |
| Export unit price (€/t) | 20,751 | 34,540 | +66.5% |
| Import value (€ million) | 640 | 712 | +11.3% |
| Import volume (tonnes) | 63,605 | 71,407 | +12.3% |
| Import unit price (€/t) | 10,054 | 9,971 | −0.8% |
| Trade balance (€ million) | −130 | +105 | — |
Import growth followed the opposite pattern: volume-led, price-stable
While exports upgraded on price, imports grew on volume. The EU's extra-EU imports increased by 12.3% in tonnage (from 63,605 t to 71,407 t) while the average import price remained essentially flat at around €10,000/tonne (−0.8%). This suggests that the EU continued to source relatively standardised medicated dressing products from third countries at stable prices, while simultaneously repositioning its own exports toward more specialised, higher-value segments. The divergence between the export price trajectory (+66.5%) and the import price trajectory (−0.8%) is the single most important economic feature of this market over the decade.
EU production grew in parallel with rising export capacity
EU domestic production of CN 300590 (measured via PRODCOM) increased from €945 million in 2015 to €1,115 million in 2025 (+17.9%), with a trough at €606 million. The export propensity — exports as a share of production — surged from 18.5% to 78.7%, indicating that EU manufacturers increasingly oriented their output toward international markets rather than the domestic one. Similarly, trade intensity (imports + exports as a share of production) rose from 37.4% to 87.3%, marking a dramatic opening of the EU market to global flows in this product category.
2. Geographic Reorientation: The US as the Dominant Growth Engine
The United States became the EU's largest export market by a wide margin
Among the EU's top export partners, the United States stands out as the primary growth driver. EU exports to the US grew from €146 million in 2015 to €253 million in 2025, an increase of 72.8%, making the US comfortably the EU's largest non-EU destination for medicated dressings — surpassing the United Kingdom (€129 million in 2025) by nearly €125 million. The coefficient of variation of EU exports to the US was only 0.049 — the lowest among all major partners — indicating remarkably stable, monotonic growth rather than episodic surges.
| Export partner | 2015 (€M) | 2025 (€M) | Change | CV |
|---|---|---|---|---|
| United States | 146 | 253 | +72.8% | 0.049 |
| United Kingdom | 113 | 129 | +13.7% | 0.157 |
| Switzerland | 64 | 66 | +2.6% | 0.171 |
| Australia | 16 | 34 | +107.5% | 0.138 |
| Norway | 21 | 25 | +19.3% | 0.066 |
| Saudi Arabia | 14 | 19 | +34.9% | 0.522 |
| Russian Federation | 14 | 12 | −14.8% | 0.408 |
Australia emerged as the fastest-growing secondary export market
Beyond the US, the most dynamic growth story was Australia: EU exports doubled from €16 million to €34 million (+107.5%), reflecting growing demand for European-origin medicated dressings in the Asia-Pacific region. Norway (+19.3%) and Saudi Arabia (+34.9%) also posted solid gains, while Russia recorded a decline (−14.8%), likely influenced by geopolitical sanctions and trade restrictions following 2022. The export concentration HHI fell from 1,553 to 1,368, confirming that the EU's export base became more diversified over the period despite the growing weight of the US.
On the import side, China consolidated its dominant position while Mexico collapsed
China remained by far the EU's largest supplier of CN 300590 products, with imports rising from €298 million to €387 million (+29.9%), after peaking at €530 million in 2022 — a year that likely reflects pandemic-related stockpiling and supply chain distortions. The import concentration HHI rose from 3,017 to 3,630, indicating increasing reliance on a narrower set of suppliers. This was partly driven by the near-complete disappearance of Mexican supplies: imports from Mexico plunged from €23 million to just €2.3 million (−89.9%), the most dramatic shift among all partners. Thailand also contracted from €24 million to €14.5 million (−40.7%). Meanwhile, the United States — which was simultaneously the EU's top export market — grew as an import source from €61 million to €89 million (+45.5%), creating an increasingly intertwined transatlantic trade relationship in this product.
| Import partner | 2015 (€M) | 2025 (€M) | Change | CV |
|---|---|---|---|---|
| China | 298 | 387 | +29.9% | 0.098 |
| United Kingdom | 167 | 158 | −5.5% | 0.227 |
| United States | 61 | 89 | +45.5% | 0.251 |
| India | 16 | 16 | +1.2% | 0.132 |
| Türkiye | 5 | 7 | +34.8% | 0.176 |
| Mexico | 23 | 2 | −89.9% | 0.537 |
| Thailand | 24 | 14 | −40.7% | 0.347 |
The Netherlands emerged as the EU's fastest-growing export hub
Among EU Member States, the Netherlands recorded the most extraordinary export growth: from €53 million in 2015 to €234 million in 2025 (+343.9%), leapfrogging Germany, Belgium, Ireland, and France to become the EU's largest exporting Member State in this product. Germany, the traditional leader, grew more modestly from €120 million to €170 million (+42.3%). On the import side, Germany remained the largest EU importer (€164 million), though it recorded a decline (−10.6%), while the Netherlands' imports grew from €91 million to €141 million (+54.2%). The Netherlands' dual role as a fast-growing importer and an even faster-growing exporter points to its function as a major re-export and distribution hub within Europe.
3. Sub-Product Divergence: Textile Bandages Drove the Price Surge
CN 30059050 (textile bandages) was the dominant segment driving the export price boom
The sub-product breakdown reveals that the export price surge was not uniform across all categories. The largest contributor was CN 30059050 — bandages and similar articles of textile materials impregnated with pharmaceutical substances. EU exports of this sub-category more than doubled in value from €197 million to €406 million, while volumes fluctuated between 8,400 and 12,500 tonnes. The unit price skyrocketed from €16,916/tonne in 2015 to a peak of €36,092/tonne in 2024 before marginally settling at €35,997/tonne in 2025. This dramatic price escalation in the largest export sub-category is the principal mechanism behind the aggregate export price increase documented earlier.
| Sub-product | 2015 value (€M) | 2025 value (€M) | 2015 price (€/t) | 2025 price (€/t) |
|---|---|---|---|---|
| 30059050 – Textile bandages | 197 | 406 | 16,916 | 35,997 |
| 30059099 – Non-textile bandages | 234 | 330 | 29,038 | 42,869 |
| 30059031 – Gauze (textile) | 45 | 47 | 16,045 | 16,317 |
| 30059010 – Wadding | 32 | 34 | 16,233 | 18,772 |
Non-textile bandages (30059099) maintained the highest unit value but grew more modestly
CN 30059099 — bandages and similar articles not made of textile materials — was the highest-priced sub-product throughout the period, with export unit values rising from €29,038/tonne to €42,869/tonne (+47.6%). Its export value grew from €234 million to €330 million (+40.7%), but export volumes actually declined from 8,073 tonnes to 7,690 tonnes. This segment likely captures more specialised wound care and advanced dressing products with higher pharmaceutical content. The combination of rising prices and falling volumes in this category reinforces the interpretation that the EU's export strategy has shifted toward higher-margin products.
The wadding sub-category (30059010) exhibited pronounced pandemic volatility
CN 30059010 — wadding impregnated with pharmaceutical substances — showed the most volatile trajectory. Import values spiked from €28 million (2015) to €63 million in 2020, then to €72 million in 2022, before settling at €46 million in 2025. On the export side, this sub-category surged to €71 million in 2020 (from €41 million in 2019) before collapsing to €22 million in 2023 and recovering to €34 million in 2025. The 2020 spike on both sides is consistent with pandemic-driven demand for basic medical wadding and gauze products, followed by a sharp normalisation as emergency stockpiles were drawn down and supply chains stabilised.
Import sub-segments remained more stable in price, confirming the asymmetric upgrading dynamic
On the import side, unit prices across the four sub-categories were considerably more stable than on the export side. CN 30059031 (gauze of textile materials) — the largest import sub-category by volume at approximately 30,000 tonnes — saw its import price decline from €7,656/tonne to €6,769/tonne. CN 30059050 import prices rose from €9,892/tonne to €10,667/tonne, a modest +7.8% compared to the +113% surge in its export price. This stark asymmetry confirms that the EU increasingly positioned itself at the premium end of the global medicated dressings market: importing standardised, lower-cost products while exporting higher-specification, higher-priced ones.
Conclusion
The EU's trade in CN 300590 over 2015–2025 tells a story of structural upgrading and geographic reorientation. The bloc transformed from a net importer with a €130 million deficit to a net exporter with a €105 million surplus, driven overwhelmingly by a 66.5% increase in export unit prices rather than volume growth. The United States emerged as the dominant and most stable export market, while China consolidated its role as the primary import supplier — though import concentration increased overall, raising potential supply-chain vulnerability concerns. Within the EU, the Netherlands emerged as the leading export hub, displacing Germany. At the sub-product level, the textile bandages segment (30059050) was the engine of the export price boom, with unit prices more than doubling. The pandemic period (2020–2022) introduced sharp but temporary disruptions, particularly in the wadding sub-category, followed by rapid normalisation. Looking at the specialisation data, Czechia and the Netherlands displayed the strongest revealed comparative advantages, suggesting that these Member States may be the primary loci of the value-added production driving the EU's export upgrading.